Pathology of Malignant Neoplasms of the Ear and Temporal Bone

  • Diana Bell


The chapter highlights the malignant neoplasms of the temporal bone. Tumors of the ear can be divided into external auditory canal (EAC) and pinna tumors, middle ear tumors, and inner ear tumors. Tumors of the middle and inner ear are grouped together, as their sites of origin cannot always be determined. The classification reflects the state of current understanding for the uncommon entities.


External ear canal Middle ear Inner ear 


  1. 1.
    Farley RL, Manolidis S, Ratner D. Aggressive basal cell carcinoma with invasion of the parotid gland, facial nerve, and temporal bone. Dermatol Surg. 2006;32:307–15; discussion 15.PubMedGoogle Scholar
  2. 2.
    Goldman NC, Hardcastle B. Partial temporal bone resection for basal cell carcinoma of the external auditory canal with preservation of facial nerve and hearing. Laryngoscope. 1974;84:84–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Gussack GS, Schlitt M, Lushington A, Woods KE. Invasive basal cell carcinoma of the temporal bone. Ear Nose Throat J. 1989;68:605–6, 9–11.Google Scholar
  4. 4.
    Lasso JM, Garcia-Tutor E, Bazan A. Aggressive basal cell carcinoma of the temporal region in a patient with Gorlin-Goltz syndrome. Ann Plast Surg. 2000;44:429–34.PubMedCrossRefGoogle Scholar
  5. 5.
    Nelson WR, Kell JF Jr, Kay S. Temporal bone resection and radical neck dissection for basal cell carcinoma with metastases. Surg Gynecol Obstet. 1962;115:585–92.PubMedGoogle Scholar
  6. 6.
    Parkin JL, Stevens MH. Basal cell carcinoma of the temporal bone. Otolaryngol Head Neck Surg. 1979;87:645–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Ouaz K, Robier A, Lescanne E, Bobillier C, Moriniere S, Bakhos D. Cancer of the external auditory canal. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:175–82.PubMedCrossRefGoogle Scholar
  8. 8.
    Johns ME, Headington JT. Squamous cell carcinoma of the external auditory canal. A clinicopathologic study of 20 cases. Arch Otolaryngol. 1974;100:45–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Fleiner F, Jumah M, Goktas O. Cancer of the external auditory canal-diagnostic and treatment. Ind J Otolaryngol Head Neck Surg. 2009;61(4):270.CrossRefGoogle Scholar
  10. 10.
    Lo WC, Ting LL, Ko JY, Lou PJ, Yang TL, Chang YL, et al. Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. Laryngoscope. 2008;118:2151–5.CrossRefGoogle Scholar
  11. 11.
    Shu MT, Lin HC, Lee JC, Chen BF. Radiation-induced squamous cell carcinoma of the external auditory canal. Otol Neurotol. 2011;32:e24–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Miah MS, Crawford M, White SJ, Hussain SS. Malignant transformation from benign papillomatosis of the external auditory canal. Otol Neurotol. 2012;33:643–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Clark RR, Soutar DS, Hunter KD. A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology. 2010;57:138–46.PubMedCrossRefGoogle Scholar
  14. 14.
    Mazzoni A, Danesi G, Zanoletti E. Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes. Acta Otorhinolaryngol Ital. 2014;34:129–37.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Nyrop M, Grontved A. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg. 2002;128(7):834.CrossRefGoogle Scholar
  16. 16.
    Wermker K, Kluwig J, Schipmann S, Klein M, Schulze HJ, Hallermann C. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear. Eur J Surg Oncol. 2015;41:128–35.PubMedCrossRefGoogle Scholar
  17. 17.
    Bono A, Bartoli C, Maurichi A, Moglia D, Tragni G. Melanoma of the external ear. Tumori. 1997;83:814–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Crain N, Nelson BL, Barnes EL, Thompson LD. Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases. Head Neck Pathol. 2009;3:1–17.PubMedCrossRefGoogle Scholar
  19. 19.
    Jan JC, Wang CP, Kwan PC, Wu SH, Shu HF. Ceruminous adenocarcinoma with extensive parotid, cervical, and distant metastases: case report and review of literature. Arch Otolaryngol Head Neck Surg. 2008;134(6):663.PubMedCrossRefGoogle Scholar
  20. 20.
    Perzin KH, Gullane P, Conley J. Adenoid cystic carcinoma involving the external auditory canal. A clinicopathologic study of 16 cases. Cancer. 1982;50:2873–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Dehner LP, Chen KT. Primary tumors of the external and middle ear. Benign and malignant glandular neoplasms. Arch Otolaryngol. 1980;106:13–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Lynde CW, McLean DI, Wood WS. Tumors of ceruminous glands. J Am Acad Dermatol. 1984;11:841–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Michel RG, Woodard BH, Shelburne JD, Bossen EH. Ceruminous gland adenocarcinoma: a light and electron microscopic study. Cancer. 1978;41:545–53.PubMedCrossRefGoogle Scholar
  24. 24.
    Ito K, Ito T, Tsukuda M, Kanisawa M. An immunohistochemical study of adenoid cystic carcinoma of the external auditory canal. Eur Arch Otorhinolaryngol. 1993;250:240–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Lott Limbach AA, Hoschar AP, Thompson LD, Stelow EB, Chute DJ. Middle ear adenomas stain for two cell populations and lack myoepithelial cell differentiation. Head Neck Pathol. 2012;6:345–53.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106:18740–4.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Persson M, Andren Y, Moskaluk CA, Frierson HF Jr, Cooke SL, Futreal PA, et al. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Genes Chromosomes Cancer. 2012;51:805–17.PubMedCrossRefGoogle Scholar
  28. 28.
    Mansour P, George MK, Pahor AL. Ceruminous gland tumours: a reappraisal. J Laryngol Otol. 1992;106:727–32.PubMedCrossRefGoogle Scholar
  29. 29.
    Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the temporal bone. Laryngoscope. 2010;120:1144–51.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Hu XD, Wu TT, Zhou SH. Squamous cell carcinoma of the middle ear: report of three cases. Int J Clin Exp Med. 2015;8:2979–84.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Michaels L, Wells M. Squamous cell carcinoma of the middle ear. Clin Otolaryngol Allied Sci. 1980;5:235–48.PubMedCrossRefGoogle Scholar
  32. 32.
    Bell D, El-Naggar AK, Gidley PW. Middle ear adenomatous neuroendocrine tumor: a 25-year experience at MD Anderson Cancer Center. Virchow Arch. 2017. 471:667–72. PMID 28547535.PubMedCrossRefGoogle Scholar
  33. 33.
    Torske KR, Thompson LD. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol. 2002;15:543–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Agaimy A, Lell M, Schaller T, Markl B, Hornung J. ‘Neuroendocrine’ middle ear adenomas: consistent expression of the transcription factor ISL1 further supports their neuroendocrine derivation. Histopathology. 2015;66:182–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Dogru S, Wilkinson EP, Robinson RA, Smith RJ. Middle ear adenoma with neuroendocrine differentiation (MEA-ND) in the pediatric population. Int J Pediatr Otorhinolaryngol. 2009;73:895–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Pelosi S, Koss S. Adenomatous tumors of the middle ear. Otolaryngol Clin N Am. 2015;48:305–15.CrossRefGoogle Scholar
  37. 37.
    Saliba I, Evrard AS. Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J. 2009;2:6508.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Duderstadt M, Forster C, Welkoborsky HJ, Ostertag H. Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions. Eur Arch Otorhinolaryngol. 2012;269:823–31.PubMedCrossRefGoogle Scholar
  39. 39.
    Gaffey MJ, Mills SE, Fechner RE, Intemann SR, Wick MR. Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma. Am J Surg Pathol. 1988;12:790–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer. 1989;64:2292–302.PubMedCrossRefGoogle Scholar
  41. 41.
    Hassard AD, Boudreau SF, Cron CC. Adenoma of the endolymphatic sac. J Otolaryngol. 1984;13:213–6.PubMedGoogle Scholar
  42. 42.
    Stendel R, Suess O, Prosenc N, Funk T, Brock M. Neoplasm of endolymphatic sac origin: clinical, radiological and pathological features. Acta Neurochir. 1998;140:1083–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Bell D, Gidley P, Levine N, Fuller GN. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience. Ann Diagn Pathol. 2011;15:117–23.PubMedCrossRefGoogle Scholar
  44. 44.
    Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol. 1994;18:1254–60.PubMedCrossRefGoogle Scholar
  45. 45.
    Bambakidis NC, Rodrigue T, Megerian CA, Ratcheson RA. Endolymphatic sac tumor metastatic to the spine. Case report. J Neurosurg Spine. 2005;3:68–70.PubMedCrossRefGoogle Scholar
  46. 46.
    Tay KY, Yu E, Kassel E. Spinal metastasis from endolymphatic sac tumor. AJNR Am J Neuroradiol. 2007;28:613–4.PubMedGoogle Scholar
  47. 47.
    Bambakidis NC, Megerian CA, Ratcheson RA. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol. 2004;25:773–81.PubMedCrossRefGoogle Scholar
  48. 48.
    Kawabata S, Hollander MC, Munasinghe JP, Brinster LR, Mercado-Matos JR, Li J, et al. Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone. Oncotarget. 2015;6:11357–68.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Iemoto Y, Ushigome S, Ikegami M, Koide K. Case report 648: parosteal osteosarcoma arising from the right temporal bone. Skelet Radiol. 1991;20:59–61.Google Scholar
  50. 50.
    Nora FE, Unni KK, Pritchard DJ, Dahlin DC. Osteosarcoma of extragnathic craniofacial bones. Mayo Clin Proc. 1983;58:268–72.PubMedGoogle Scholar
  51. 51.
    Sanal HT, Kilickesmez O, Can C. Radiology quiz case 2. Classic osteosarcoma of the temporal bone. Arch Otolaryngol Head Neck Surg. 2005;131:922, 6.CrossRefGoogle Scholar
  52. 52.
    Huvos AG, Sundaresan N, Bretsky SS, Butler A. Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer. 1985;56:1214–21.PubMedCrossRefGoogle Scholar
  53. 53.
    Sundaresan N, Galicich JH, Rosen G, Huvos AG. Primary osteogenic sarcoma of the skull. Five-year disease-free survival following surgery and high dose methotrexate therapy. N Y State J Med. 1985;85:598–9.PubMedGoogle Scholar
  54. 54.
    Sundaresan N, Huvos AG, Rosen G, Galicich JH. Combined-modality treatment of osteogenic sarcoma of the skull. J Neurosurg. 1985;63:562–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Kakkar A, Nambirajan A, Suri V, Sarkar C, Kale SS, Singh M, et al. Primary bone tumors of the skull: spectrum of 125 cases, with review of literature. J Neurol Surg B Skull Base. 2016;77:319–25.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Choi EY, Gardner JM, Lucas DR, McHugh JB, Patel RM. Ewing sarcoma. Semin Diagn Pathol. 2014;31:39–47.PubMedCrossRefGoogle Scholar
  57. 57.
    Carroll R, Miketic LM. Ewing sarcoma of the temporal bone: CT appearance. J Comput Assist Tomogr. 1987;11:362–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Pfeiffer J, Boedeker CC, Ridder GJ. Primary Ewing sarcoma of the petrous temporal bone: an exceptional cause of facial palsy and deafness in a nursling. Head Neck. 2006;28:955–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Souviron Encabo R, Arenas Britez O, Gil R, Perez-Luengo E, Scola Yurrita B. Primitive neuroectodermal tumor/extraosseus Ewing sarcoma of the temporal bone. Acta Otorrinolaringol Esp. 2005;56:38–40.PubMedCrossRefGoogle Scholar
  60. 60.
    Hart JL, Edgar MA, Gardner JM. Vascular tumors of bone. Semin Diagn Pathol. 2014;31:30–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Chen F, Hu H, Li J, Yang W. A case of temporal bone epithelioid hemangioendothelioma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49:603–4.PubMedGoogle Scholar
  62. 62.
    Eliashar R, Saah D, Osin P, Sichel JY. Hemangioendothelioma of the temporal bone in a child. Int J Pediatr Otorhinolaryngol. 1997;40:67–71.PubMedCrossRefGoogle Scholar
  63. 63.
    Goldstein WS, Bowen BC, Balkany T. Malignant hemangioendothelioma of the temporal bone masquerading as glomus tympanicum. Ann Otol Rhinol Laryngol. 1994;103:156–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Ibarra RA, Kesava P, Hallet KK, Bogaev C. Hemangioendothelioma of the temporal bone with radiologic findings resembling hemangioma. AJNR Am J Neuroradiol. 2001;22:755–8.PubMedGoogle Scholar
  65. 65.
    Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48:63–74.PubMedCrossRefGoogle Scholar
  66. 66.
    Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38:552–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Chin LS, Rabb CH, Hinton DR, Apuzzo ML. Hemangiopericytoma of the temporal bone presenting as a retroauricular mass. Neurosurgery. 1993;33:728–31; discussion 31–2.PubMedCrossRefGoogle Scholar
  68. 68.
    Coca-Pelaz A, Llorente-Pendas JL, Vivanco-Allende B, Suarez-Nieto C. Solitary fibrous tumor of the petrous bone: a successful treatment option. Acta Otolaryngol. 2011;131:1349–52.PubMedCrossRefGoogle Scholar
  69. 69.
    Colia V, Provenzano S, Hindi N, Casali PG, Stacchiotti S. Systemic therapy for selected skull base sarcomas: chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma. Rep Pract Oncol Radiother. 2016;21:361–9.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Cross DL, Mixon C. Temporal bone hemangiopericytoma. Otolaryngol Head Neck Surg. 1996;114:631.PubMedCrossRefGoogle Scholar
  71. 71.
    Heiser MA, Waldron JS, Tihan T, Parsa AT, Cheung SW. Temporal fossa hemangiopericytoma: a case series. Otol Neurotol. 2009;30:985–9.PubMedCrossRefGoogle Scholar
  72. 72.
    Kamrava B, Mukherjee A, Weaver M, Roehm PC. Temporal malignant solitary fibrous tumor. Otol Neurotol. 2016;37:e185–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Magliulo G, Terranova G, Cordeschi S. Hemangiopericytoma and temporal bone. An Otorrinolaringol Iberoam. 1999;26:67–74.Google Scholar
  74. 74.
    Tewfik TL, Finlayson M, Attia EL. Hemangiopericytoma of the temporal bone. J Otolaryngol. 1981;10:72–7.PubMedGoogle Scholar
  75. 75.
    Grubbe Gregersen K, Hansen S. Metastasis to the temporal bone may cause acute peripheral vestibular syndrome and impaired hearing. Ugeskr Laeger. 2013;175:1576–7.PubMedGoogle Scholar
  76. 76.
    Jalava-Karvinen P, Kemppainen J, Saario R, Kotilainen P. Metastasis in the temporal bone mimicking temporal arteritis. J Clin Rheumatol. 2010;16:19–21.PubMedCrossRefGoogle Scholar
  77. 77.
    Vize G. Laryngeal metastasis to the temporal bone causing facial paralysis. J Laryngol Otol. 1974;88:175–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Wu C, Kaga K, Ohira Y, Suzuki J. Histopathology of multiple temporal bone metastasis from pancreatic adenocarcinoma: a case showing bilateral hearing loss and Bechterew’s phenomenon. Otolaryngol Head Neck Surg. 2000;122:613–5.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Departments of Pathology and Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations